All In Biotech

Free tool

FAERS Monitor: Biktarvy

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 210251 or its brand name (Biktarvy, Bictegravir Sodium, Emtricitabine, Tenofovir Alafenamide Fumarate). Reports on generic versions are filed under their own applications.

Reports

18,385

Serious

13,377

73% of reports

Hospitalization

2,244

Death reported

732

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • bone density decreased6,649
  • chronic kidney disease3,668
  • bone loss3,491
  • tooth loss3,445
  • osteonecrosis3,405
  • multiple fractures3,153
  • renal failure3,059
  • osteoporosis2,794
  • pain2,549
  • renal injury2,489
  • emotional distress2,436
  • anxiety2,283
  • anhedonia2,154
  • skeletal injury2,123
  • osteopenia1,884

Reports by year received

View as table
YearReports
20101
20151
20167
20171
2018363
20191,482
20205,609
20212,570
20222,257
20231,630
20241,854
20251,709
2026901

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,035,774 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
bone lossSignal3,491345.6333.7921,689
bone density decreasedSignal6,649307.8300.81,604,418
skeletal injurySignal2,123295.2282.1494,802
multiple fracturesSignal3,153271.4261.8686,958
tooth lossSignal3,445227.7220.2648,977
osteopeniaSignal1,884162.0154.7264,120
osteonecrosisSignal3,405132.2128.0397,891
renal injurySignal2,489104.5100.6234,024
anhedoniaSignal2,154102.097.9198,016
osteoporosisSignal2,79483.380.4212,104
chronic kidney diseaseSignal3,66858.056.3196,131
renal failureSignal3,05927.026.175,126
emotional distressSignal2,43623.522.651,629
anxietySignal2,2839.28.916,869
painSignal2,5494.84.67,769

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.